Abstract
Despite the development of modern technologies in the field of healthcare and the wide application of modern diagnostic and treatment methods, mortality from ischemic heart disease remains the leading cause of death among diseases. It is known that coronary artery bypass grafting in combination with optimal medical therapy is the gold standard for treating patients with multivessel coronary artery disease. However, for several decades now, percutaneous coronary intervention has proven to be an alternative method of myocardial revascularization for patient with multivessel coronary artery disease and low or intermediate risk. Nevertheless, despite accumulated experience in treating patients with ischemic heart disease, the choice of revascularization method for patients with complex coronary artery disease and high surgical risk (not eligible for CABG) remains debatable. In this review article, the authors described the main factors influencing the choice of myocardial revascularization strategy and demonstrated the results of clinical studies dedicated to studying this issue.

This publication has 49 references indexed in Scilit: